advertisement

---

Ye Q 8

Showing records 1 to 8 | Display all abstracts from Ye Q

105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Huang L
Frontiers in pharmacology 2022; 13: 990401

---

106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Huang L
Biochemical Pharmacology 2022; 206: 115340

---

105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Ye Q
Frontiers in pharmacology 2022; 13: 990401

---

106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Wei Z; Wang X
Biochemical Pharmacology 2022; 206: 115340

---

105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Lan C; Wang X
Frontiers in pharmacology 2022; 13: 990401

---

106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Lan C
Biochemical Pharmacology 2022; 206: 115340

---

105975 AZD6738 Inhibits fibrotic response of conjunctival fibroblasts by regulating checkpoint kinase 1/ and / pathways
Zhu Y
Frontiers in pharmacology 2022; 13: 990401

---

106287 AZD6738 decreases intraocular pressure and inhibits fibrotic response in trabecular meshwork through CHK1/P53 pathway
Zhu Y; Ye Q
Biochemical Pharmacology 2022; 206: 115340

---